The Global Gummy Supplements Market reached USD 24.34 billion in 2023 and is expected to reach USD 66.79 billion by 2031, growing at a strong CAGR of 13.6% during the forecast period 2024-2031.

Market growth is driven by rising consumer preference for convenient and palatable dietary supplements, increasing awareness of preventive healthcare, and growing demand for vitamins, minerals, and herbal supplements in gummy form. Additionally, expanding adoption among children and adults, continuous product innovations with sugar-free and plant-based formulations, and the widening availability of gummy through online and retail channels are further accelerating market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/gummy-supplements-market?ram

United States: Key Industry Developments

✅ October 2025: Zhou Nutrition unveiled five new gummy supplements including Colostrum, Shilajit, Irish Sea Moss, Beetroot, and Magnesium Glycinate, targeting immunity, digestion, and overall wellness with plant-based, science-backed ingredients.

✅ September 2025: TopGum expanded across North America with functional gummy supporting immunity, sleep, energy, and beauty, leveraging advanced production for precise dosing in the U.S. wellness market.

✅ July 2025: Bayer launched One A Day® Kids Multi with Iron, a gummy multivitamin supplement featuring 12mg of iron per serving to address nutritional needs in children.

Asia Pacific / Japan: Key Industry Developments

✅ November 2025: Otsuka Pharmaceutical introduced probiotic-infused gummy supplements aimed at digestive wellness, capitalizing on rising demand for functional nutrition in Japan.

✅ October 2025: Japanese nutraceutical firms launched new adult-focused functional gummy in beauty-from-within and energy categories amid growing consumer preferences.

✅ September 2025: Japanese companies adopted low-sugar and collagen-rich gummy formulations to align with health-conscious trends and expand market appeal.

Key Merges and Acquisitions(2025):

✅ A leading nutraceutical firm expanded its North American production footprint through strategic acquisitions of key gummy manufacturing assets, significantly boosting capacity for vitamin and immune support formulations.

✅ An established supplement manufacturer strengthened its European market position by acquiring multiple specialized production sites focused on gummy formats, enhancing distribution in pharmacies and retail channels.

✅ Major industry players collaborated on innovative probiotic and collagen-infused gummy technologies to address rising demand in Asia Pacific wellness segments.

Market Segmentation Analysis:

-By Type: Vitamins Lead with 45% Share

Vitamins dominate at 45% market share in 2025, fueled by demand for immune-boosting and multivitamin gummy among health-conscious consumers seeking convenient daily nutrition.

Minerals hold 25%, targeting bone health and electrolyte balance with formulations like calcium and magnesium blends.

Probiotics/prebiotics claim 15%, botanicals/herbals 10%, and specialty nutrients/others 5%, driven by gut health trends and natural extracts.

-By End-User: Adults Dominate at 55%

Adults lead with 55% share, appealing to busy professionals via targeted wellness like stress relief and energy support.

Children/kids follow at 25%, popular for fun, flavored immune and vitamin options parents prefer over pills.

Seniors hold 15% for joint and cognitive health, while pregnant women/others take 5% focused on prenatal nutrition.

-By Distribution Channel: Offline Retail Tops at 60%

Offline channels like supermarkets/hypermarkets and pharmacies command 60%, offering impulse buys and trusted in-store advice.

Online/e-commerce grows at 30%, boosted by direct-to-consumer brands and subscription models for convenience.

Specialty stores/others account for 10%, catering to niche health shops.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=gummy-supplements-market?ram (Purchase 2 or more Reports and get 50% Discount)

Why is the Gummy Supplements Market Growing?

The rapid expansion of the Gummy Supplements market in 2025 is fueled by several critical factors:

-Rising Health Consciousness: Consumers increasingly seek convenient, enjoyable alternatives to traditional pills, boosting demand for functional gummy targeting immunity, vitamins, and wellness.

-Preference for Tasty Formats: The fun, candy-like appeal overcomes supplement fatigue, especially among children, seniors, and busy adults prioritizing palatable nutrition.

-Plant-Based and Clean-Label Trends: Surging interest in vegan, sugar-free, and natural ingredients like ashwagandha and spirulina drives innovation in sustainable formulations.

-E-Commerce and Regional Growth: Expanded online access and rising disposable incomes in Asia-Pacific and North America accelerate adoption of personalized, immunity-boosting products.

Regional Insights:

-North America leads the Gummy Supplements Market with the highest regional share, accounting for approximately 44% of the global market in recent years, driven by strong consumer demand for convenient nutrition, robust manufacturing presence, and high awareness of health supplements in countries like the US and Canada.

-Europe follows as the second-largest region, benefiting from increasing adoption of gummy formats among health-conscious adults and children, alongside a mature retail infrastructure and rising nutritional deficiency concerns, though exact share figures hover below North America’s dominance.

-Asia Pacific ranks third in market share, showing the fastest growth potential due to expanding middle-class populations, rising disposable incomes, and preferences for palatable supplements in nations like China, India, and Japan, fueled by wellness trends and local flavor innovations.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/gummy-supplements-market?ram

Key Players:

Amway Corp. | Bayer AG | Haleon Group of Companies | Nestle | Hero Nutritionals, Inc. | Unilever | Herbaland USA | Nature’s Truth | Otsuka Pharmaceutical Co., Ltd.

Key Highlights (Top 4 Key Players) for Gummy Supplements Market:

-Amway Corp. expands its Nutrilite gummy vitamins line, particularly for children’s growth and development with essential nutrients, leveraging its global multi-level marketing network.​

-Bayer AG provides gummy supplements as part of its consumer health portfolio, emphasizing vitamins, minerals, and targeted wellness formulations through strong distribution channels.​

-Haleon Group of Companies delivers gummy vitamins and supplements via brands like Centrum, prioritizing immunity, digestion, and daily health needs with innovative formats.​

-Nestle launches gummy supplements under its Wellness by Nestle brand, targeting specific health areas like immunity and energy with nutrient-specific formulations.​

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us –

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us –

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

State

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed Forces PacificArmed Forces EuropeNorthern Mariana IslandsMarshall IslandsAmerican SamoaFederated States of MicronesiaGuamPalauAlberta, CanadaBritish Columbia, CanadaManitoba, CanadaNew Brunswick, CanadaNewfoundland, CanadaNova Scotia, CanadaNorthwest Territories, CanadaNunavut, CanadaOntario, CanadaPrince Edward Island, CanadaQuebec, CanadaSaskatchewan, CanadaYukon Territory, Canada

Zip Code

Country

United States of AmericaUS Virgin IslandsUnited States Minor Outlying IslandsCanadaMexico, United Mexican StatesBahamas, Commonwealth of theCuba, Republic ofDominican RepublicHaiti, Republic ofJamaicaAfghanistanAlbania, People’s Socialist Republic ofAlgeria, People’s Democratic Republic ofAmerican SamoaAndorra, Principality ofAngola, Republic ofAnguillaAntarctica (the territory South of 60 deg S)Antigua and BarbudaArgentina, Argentine RepublicArmeniaArubaAustralia, Commonwealth ofAustria, Republic ofAzerbaijan, Republic ofBahrain, Kingdom ofBangladesh, People’s Republic ofBarbadosBelarusBelgium, Kingdom ofBelizeBenin, People’s Republic ofBermudaBhutan, Kingdom ofBolivia, Republic ofBosnia and HerzegovinaBotswana, Republic ofBouvet Island (Bouvetoya)Brazil, Federative Republic ofBritish Indian Ocean Territory (Chagos Archipelago)British Virgin IslandsBrunei DarussalamBulgaria, People’s Republic ofBurkina FasoBurundi, Republic ofCambodia, Kingdom ofCameroon, United Republic ofCape Verde, Republic ofCayman IslandsCentral African RepublicChad, Republic ofChile, Republic ofChina, People’s Republic ofChristmas IslandCocos (Keeling) IslandsColombia, Republic ofComoros, Union of theCongo, Democratic Republic ofCongo, People’s Republic ofCook IslandsCosta Rica, Republic ofCote D’Ivoire, Ivory Coast, Republic of theCyprus, Republic ofCzech RepublicDenmark, Kingdom ofDjibouti, Republic ofDominica, Commonwealth ofEcuador, Republic ofEgypt, Arab Republic ofEl Salvador, Republic ofEquatorial Guinea, Republic ofEritreaEstoniaEthiopiaFaeroe IslandsFalkland Islands (Malvinas)Fiji, Republic of the Fiji IslandsFinland, Republic ofFrance, French RepublicFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabon, Gabonese RepublicGambia, Republic of theGeorgiaGermanyGhana, Republic ofGibraltarGreece, Hellenic RepublicGreenlandGrenadaGuadaloupeGuamGuatemala, Republic ofGuinea, Revolutionary
People’s Rep’c ofGuinea-Bissau, Republic ofGuyana, Republic ofHeard and McDonald IslandsHoly See (Vatican City State)Honduras, Republic ofHong Kong, Special Administrative Region of ChinaHrvatska (Croatia)Hungary, Hungarian People’s RepublicIceland, Republic ofIndia, Republic ofIndonesia, Republic ofIran, Islamic Republic ofIraq, Republic ofIrelandIsrael, State ofItaly, Italian RepublicJapanJordan, Hashemite Kingdom ofKazakhstan, Republic ofKenya, Republic ofKiribati, Republic ofKorea, Democratic People’s Republic ofKorea, Republic ofKuwait, State ofKyrgyz RepublicLao People’s Democratic RepublicLatviaLebanon, Lebanese RepublicLesotho, Kingdom ofLiberia, Republic ofLibyan Arab JamahiriyaLiechtenstein, Principality ofLithuaniaLuxembourg, Grand Duchy ofMacao, Special Administrative Region of ChinaMacedonia, the former Yugoslav Republic ofMadagascar, Republic ofMalawi, Republic ofMalaysiaMaldives, Republic ofMali, Republic ofMalta, Republic ofMarshall IslandsMartiniqueMauritania, Islamic Republic ofMauritiusMayotteMicronesia, Federated States ofMoldova, Republic ofMonaco, Principality ofMongolia, Mongolian People’s RepublicMontserratMorocco, Kingdom ofMozambique, People’s Republic ofMyanmarNamibiaNauru, Republic ofNepal, Kingdom ofNetherlands AntillesNetherlands, Kingdom of theNew CaledoniaNew ZealandNicaragua, Republic ofNiger, Republic of theNigeria, Federal Republic ofNiue, Republic ofNorfolk IslandNorthern Mariana IslandsNorway, Kingdom ofOman, Sultanate ofPakistan, Islamic Republic ofPalauPalestinian Territory, OccupiedPanama, Republic ofPapua New GuineaParaguay, Republic ofPeru, Republic ofPhilippines, Republic of thePitcairn IslandPoland, Polish People’s RepublicPortugal, Portuguese RepublicPuerto RicoQatar, State ofReunionRomania, Socialist Republic ofRussian FederationRwanda, Rwandese RepublicSamoa, Independent State ofSan Marino, Republic ofSao Tome and Principe, Democratic Republic ofSaudi Arabia, Kingdom ofSenegal, Republic ofSerbia and MontenegroSeychelles, Republic ofSierra Leone, Republic ofSingapore, Republic ofSlovakia (Slovak Republic)SloveniaSolomon IslandsSomalia, Somali RepublicSouth Africa, Republic ofSouth Georgia and the South Sandwich IslandsSpain, Spanish StateSri Lanka, Democratic Socialist Republic ofSt. HelenaSt. Kitts and NevisSt. LuciaSt. Pierre and MiquelonSt. Vincent and the GrenadinesSudan, Democratic Republic of theSuriname, Republic ofSvalbard & Jan Mayen IslandsSwaziland, Kingdom ofSweden, Kingdom ofSwitzerland, Swiss ConfederationSyrian Arab RepublicTaiwan, Province of ChinaTajikistanTanzania, United Republic ofThailand, Kingdom ofTimor-Leste, Democratic Republic ofTogo, Togolese RepublicTokelau (Tokelau Islands)Tonga, Kingdom ofTrinidad and Tobago, Republic ofTunisia, Republic ofTurkey, Republic ofTurkmenistanTurks and Caicos IslandsTuvaluUganda, Republic ofUkraineUnited Arab EmiratesUnited Kingdom of Great Britain & N. IrelandUruguay, Eastern Republic ofUzbekistanVanuatuVenezuela, Bolivarian Republic ofViet Nam, Socialist Republic ofWallis and Futuna IslandsWestern SaharaYemenZambia, Republic ofZimbabwe

Marks & Spencer is launching a range of foods tailored to people taking weight-loss injections as use of the drugs accelerates in the UK.

The new range of 20 “nutrient-dense” products from the retailer is aimed at customers taking GLP-1 weight-loss medications, as supermarkets increasingly adapt to the impact the drugs are having on shopping baskets.

The range will go on sale in M&S foodhalls from January 5 and includes salads, meals and bread designed to deliver high levels of fibre, vitamins and minerals in smaller portions.

There has been a dramatic rise in the use of GLP-1 drugs in the UK. Online searches and private prescriptions have increased sharply, driven by their effectiveness for weight loss and widespread media attention. About 1.5 million people in the UK are now estimated to be accessing GLP-1 treatment privately, while NHS England prescriptions for the injections have risen by around 900 per cent since 2020.

GLP-1 medications — known formally as glucagon-like peptide-1 (GLP-1) receptor agonists — were originally developed to treat type 2 diabetes by helping to regulate blood sugar. In recent years, drugs such as semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (sold as Mounjaro) have surged in popularity for their weight-loss effects, as they suppress appetite, slow digestion and signal fullness to the brain.

• Our writers’ share tips for 2026, plus last year’s winners and losers

Nutrient-dense foods are those that provide a concentrated source of vitamins, minerals, fibre, healthy fats and protein relative to their calorie content. M&S said the range was developed by its nutritionists in consultation with the British Nutrition Foundation, using criteria that ensure each product delivers more nutrients per mouthful.

M&S said the new range had been developed to address the nutritional challenges that can arise when people eat less, whether due to medication, age or lifestyle. A reduced appetite can make it harder to consume enough fibre and essential nutrients, increasing the risk of deficiencies and digestive side effects such as constipation.

Grace Ricotti, M&S head of food nutrition, said: “Our nutrient-dense range is perfect for customers looking to support their health as each recipe is packed with the key nutrients we all need in our diets.

“With the increase in popularity of weight-loss injections, a reduced appetite can mean missing out on important nutrients and that’s why nutrient density is so important. These new meals, snacks and drinks can help everyone get more fibre, vitamins and minerals in their diet.”

Supermarkets and consumer goods companies are increasingly catering to households using the drugs. Morrisons was the first UK supermarket to announce a dedicated “GLP-1 friendly” range, developed with sports nutrition brand Applied Nutrition, under its “Small & Balanced” banner. Nestlé, the consumer goods giant, has launched a frozen food brand in the US aimed at GLP-1 users, while Haleon, the British multinational consumer healthcare company, has introduced a multivitamin designed to help replenish nutrients for people eating less.

The trend is expected to accelerate further as GLP-1 medications move beyond injections. Tablet versions are beginning to reach the market, with US regulators approving an oral version of Wegovy and rival pills expected to follow, potentially widening access to the drugs.

While the drugs are approved for diabetes and obesity treatment, clinicians have raised concerns about the number of people accessing them outside clinical pathways for cosmetic weight loss. The long-term consequences of widespread use are still being studied, particularly as lower calorie intake can increase the risk of nutrient deficiencies if diets are not carefully managed.

Marks & Spencer is launching a range of foods tailored to people taking weight-loss injections as use of the drugs accelerates in the UK.

The new range of 20 “nutrient-dense” products from the retailer is aimed at customers taking GLP-1 weight-loss medications, as supermarkets increasingly adapt to the impact the drugs are having on shopping baskets.

The range will go on sale in M&S foodhalls from January 5 and includes salads, meals and bread designed to deliver high levels of fibre, vitamins and minerals in smaller portions.

There has been a dramatic rise in the use of GLP-1 drugs in the UK. Online searches and private prescriptions have increased sharply, driven by their effectiveness for weight loss and widespread media attention. About 1.5 million people in the UK are now estimated to be accessing GLP-1 treatment privately, while NHS England prescriptions for the injections have risen by around 900 per cent since 2020.

GLP-1 medications — known formally as glucagon-like peptide-1 (GLP-1) receptor agonists — were originally developed to treat type 2 diabetes by helping to regulate blood sugar. In recent years, drugs such as semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (sold as Mounjaro) have surged in popularity for their weight-loss effects, as they suppress appetite, slow digestion and signal fullness to the brain.

• Our writers’ share tips for 2026, plus last year’s winners and losers

Nutrient-dense foods are those that provide a concentrated source of vitamins, minerals, fibre, healthy fats and protein relative to their calorie content. M&S said the range was developed by its nutritionists in consultation with the British Nutrition Foundation, using criteria that ensure each product delivers more nutrients per mouthful.

M&S said the new range had been developed to address the nutritional challenges that can arise when people eat less, whether due to medication, age or lifestyle. A reduced appetite can make it harder to consume enough fibre and essential nutrients, increasing the risk of deficiencies and digestive side effects such as constipation.

Grace Ricotti, M&S head of food nutrition, said: “Our nutrient-dense range is perfect for customers looking to support their health as each recipe is packed with the key nutrients we all need in our diets.

“With the increase in popularity of weight-loss injections, a reduced appetite can mean missing out on important nutrients and that’s why nutrient density is so important. These new meals, snacks and drinks can help everyone get more fibre, vitamins and minerals in their diet.”

Supermarkets and consumer goods companies are increasingly catering to households using the drugs. Morrisons was the first UK supermarket to announce a dedicated “GLP-1 friendly” range, developed with sports nutrition brand Applied Nutrition, under its “Small & Balanced” banner. Nestlé, the consumer goods giant, has launched a frozen food brand in the US aimed at GLP-1 users, while Haleon, the British multinational consumer healthcare company, has introduced a multivitamin designed to help replenish nutrients for people eating less.

The trend is expected to accelerate further as GLP-1 medications move beyond injections. Tablet versions are beginning to reach the market, with US regulators approving an oral version of Wegovy and rival pills expected to follow, potentially widening access to the drugs.

While the drugs are approved for diabetes and obesity treatment, clinicians have raised concerns about the number of people accessing them outside clinical pathways for cosmetic weight loss. The long-term consequences of widespread use are still being studied, particularly as lower calorie intake can increase the risk of nutrient deficiencies if diets are not carefully managed.